Long Valley, NJ, United States of America

Arthur M P Doweyko


 

Average Co-Inventor Count = 6.5

ph-index = 7

Forward Citations = 291(Granted Patents)


Company Filing History:


Years Active: 2002-2016

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Arthur M P Doweyko: Innovator in Protein Tyrosine Kinase Inhibitors

Introduction

Arthur M P Doweyko is a notable inventor based in Long Valley, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cyclic protein tyrosine kinase inhibitors. With a total of 18 patents to his name, Doweyko's work has had a profound impact on the treatment of various disorders.

Latest Patents

Among his latest patents are innovative cyclic compounds and salts that serve as protein tyrosine kinase inhibitors. These compounds are included in pharmaceutical compositions designed for the treatment of protein tyrosine kinase-associated disorders, such as immunologic and oncologic disorders. His research has paved the way for new therapeutic methods that could improve patient outcomes.

Career Highlights

Throughout his career, Doweyko has worked with prominent companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and Uniroyal Chemical Company, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.

Collaborations

Doweyko has collaborated with esteemed colleagues, including Jagabandhu Das and Joel C Barrish. These partnerships have further enhanced his research capabilities and have led to significant advancements in the field.

Conclusion

Arthur M P Doweyko stands out as a key figure in the development of innovative treatments for serious health conditions. His contributions to the field of protein tyrosine kinase inhibitors are invaluable and continue to influence pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…